Back to Journals » Drug Design, Development and Therapy » Volume 9

A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects

Total article views   HTML views PDF downloads Totals
16,164 Dovepress* 13,079+ 1,999 15,078
PubMed Central* 3,085 769 3,854
Totals 16,164 2,768 18,932
*Since 4 February 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
1 0 0 0 0 1

View citations on PubMed Central and Google Scholar